(
83
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
Apply filters
Knowledge Hub
Collapse
Website
Collapse
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen-Specific T Cells to House Dust Mite are absent on the circulation of local allergic rhinitis patients
-
Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis
-
Alterations in B cell memory induced by house dust mite allergen immunotherapy
-
Analytical Performance Evaluation of House Dust Mite Components on IMMULITE 2000 XPi Platform
-
Approach to shrimp hypersensitivity in a geographic area with high prevalence of dust mites allergy: role of molecular diagnosis
-
Assessment of symptoms and mucosal specific IgEs presence induced by NPT and natural dust mites exposure in LAR patients
-
Atopic dermatitis patients with IL-22 response by House dust mite-activated circulating CLA+ memory T cells display a distinct molecular signature in lesional skin
-
Blomia Tropicalis (a house dust mite) is the most important sensitization in patients with Allergic Airways Disease in Reunion Island (Tropical region)
-
Can the Dermatophagoides Pteronyssinus Molecular Allergen Sensitization Profile, assessed with a Skin Prick Test, Be Useful in Evaluating Clinically Relevant House Dust Mite Allergy?
-
Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis
-
China’s First Three-Dimensional Indoor Dust Mite Allergen Distribution Map: A Cross-Sectional Study of Dust Mite-Allergic Patients in Guangzhou
-
China’s semi-quantitative detection reagent for dust mites based on guanine concentration
-
Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis
-
Comparative Analysis of Nasal Secretions and Serum Biomarkers in House Dust Mite Allergy: Correlation with Symptoms and Skin Prick Test Results
-
Consistent efficacy of the SQ HDM SLIT-tablet in children (5–11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis across subgroups in the MT-12 phase III trial
-
Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort
-
Correlation between subjective and objective parameters in house dust mite nasal allergen challenge
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy
-
Development and validation of Skin Prick Test solutions for assessing sensitization patterns to edible insects among children sensitized to house dust mite
-
Dietary intervention with fructo-oligosaccharides in a mouse-model for house dust mite allergy enhances type 1, while lowering HDM specific type 2 responses in the lungs
-
Edible insects – a problem for house dust mite or food allergic children and adolescents?
-
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
-
Effectiveness of House Dust Mite Subcutaneous Immunotherapy on Co-existing Allergen Symptoms in Polysensitized Patients with Allergic Rhinitis: A Multicenter Retrospective Analysis
-
Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study
-
Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study
-
Effectivity and serological correlation analysis in patients undergoing their first year of mixed subcutaneous immunotherapy for dust mites and cat
-
Efficacy of House Dust Mite Immunotherapy in Chinese Allergic Rhinitis Patients with Diverse Sensitization Patterns: A Multicenter Study
-
Epicutaneous Allergen Administration with Microneedles as a Novel Method of Immunotherapy for House Dust Mite (HDM) Allergic Rhinitis
-
Evaluating the relevance of measurement tools in assessing the effectiveness of 12 SQ HDM SLIT-tablet for Chinese patients with moderate to severe house dust mite allergic rhinitis with or without allergic asthma: a prospective observational study
-
Evaluation of novel food proteins cross-recognition by IgEs from shrimp and house dust mite allergic patients
-
Exploring the Link: Positive House Dust Mite Skin Prick Test and its Association with the Quality of Sleep in Children with Rhinitis in Morocco
-
Extended exposure to the urban environment facilitates house dust mite IgE response and sensitizations in Chinese migrants
-
First-in-class biologic to treat House dust mite allergy
-
House Dust Mite Sensitization Profile: Insights from a Portuguese Tertiary Hospital
-
House Dust Mite Sensitization in Shrimp Sensitized Patients in Brazil
-
House dust mite and staphylococcal enterotoxin B trigger heterogeneous IL-9 production by circulating skin-tropic and non-tropic memory T cells in patients with atopic dermatitis
-
House dust mite and staphylococcal enterotoxin B trigger heterogeneous IL-9 production by circulating skin-tropic and non-tropic memory T cells in patients with atopic dermatitis
-
House dust mite molecular sensitization in a Portuguese pediatric population and urbanization: a national multicentric study
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
How individual profile of sensitisation broadens our horizons about house dust mite allergy? A presentation of results from children in Poland
-
Impact of allergic rhinitis activity on the effect of 300IR house dust mite sublingual immunotherapy tablet in adolescent patients
-
Impact of dog ownership on allergen exposure and tolerance development: Analysis of Can f 1 levels in house dust samples
-
Impact of the implementation of recommendations from the Medical Indoor Environment Counselor (MIEC) on the health evolution of patients allergic to dust mites
-
Modulation of B cell memory responses by house dust mite allergen immunotherapy
-
Modulation of allergen-specific type 2 memory B cells over the course of 18 months sublingual immunotherapy for house dust mite allergy
-
Molecular sensitization profiles in house dust mite allergic patients from Valencian Community
-
Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
-
Positive impact on quality of life with a depigmented-polymerized house dust mite extract immunotherapy
-
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
-
Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors
-
Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year
-
Safety of the SQ HDM SLIT-tablet in children (5–11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis in the MT-12 phase III trial
-
Serum Lactate Dehydrogenase levels distinguish atopic dermatitis patients with a predominant production of IL-13, IL-5 and IL-9 in response to house dust mite allergen and increased prevalence of allergic comorbidities
-
Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma
-
Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
-
Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα
-
The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The SQ HDM SLIT-tablet improves QoL and reduces clinical symptoms in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial
-
The Skin Sebum and Moisture Levels of Children with Allergic Diseases: How Predictive Are They for House Dust Mite Allergy?
-
Tropomyosin cross-reactivity in House Dust Mite sensitized patients in Brazil
-
Validation of a Skin Prick Automated Test (SPAT) cutoff value in birch pollen and house dust mite clinically allergic patients
-
Work ability in patients with perennial allergic rhinitis induced by house dust mite
-
An adjuvant-free in vivo model for the differential analysis of early Th2 versus IgE responses induced by inhalation of house dust mites
-
Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)
-
Prevalence of sensitization to house dust mites in children with allergies
-
Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
-
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in pediatric patients with allergic rhinitis due to house dust mites or pollens
-
Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
The characteristics of house dust mites molecular sensitization profile in children and adult with respiratory allergies -A single center experience
-
The characteristics of house dust mites molecular sensitization profile in children and adult with respiratory allergies -A single center experience
-
The survey of perennial allergic rhinitis caused by house dust mites among the elementary school students in Fukui, Japan
-
Expanding the evidence for the SQ house dust mite SLIT-tablet in younger children with house dust mite allergic rhinitis – new phase III results
Show more Sessions (80)Show Less-